Thanks for emailing that article!
Photos from the Glaucoma Research Foundation (GRF) Annual Dinner on April 21, 2015 at the Sir Francis Drake Hotel in San Francisco.
Pictured from left to right: GRF President and CEO Thomas M. Brunner, Scientific Advisory Board Member Monica Vetter, PhD, and Board Chair Andrew Iwach, MD.
Catalyst Circle Members Tatyana Beldock, Marilyn Fenneman, and Alex Forrester catch up during the reception.
Former board member J. Bronwyn Bateman, MD and retiring board member Arthur Takahara enjoy each other’s company during the reception.
Pictured from left to right: Board member Linda Linck, GRF Councilor Steven Vold, MD and GRF Board Chair Andrew Iwach, MD.
Catalyst Circle members Stephanie and N. D’Arcy Roche happily attend the event
Pictured from left to right: Family members Bethanne Lee, Catalyst Circle member Patricia M. Lee, and Marty Oster.
Catalyst Circle members Susan and Schuyler Bailey enjoy the reception.
Friends and colleagues Thomas M. Brunner and David Heller attend the reception.
Pictured from left to right: Charles Munnerlyn, PhD, Judy Munnerlyn, Wallace and Thomas M. Brunner attend dinner together.
Andrew Iwach, MD presents retiring board member John Grunden, PharmD with an award for his time and service as a GRF board member.
Gary Cleary and Nobuko Saito Cleary attend dinner and are honored for their continued service as Annual Gala co-chairs.
Thomas Brunner is honored by Andrew Iwach, MD and David Heller for his commitment and dedication as GRF President and CEO.
Last reviewed on October 29, 2017
Stem cells are being investigated as a possible treatment for glaucoma because they may have the potential to protect the optic nerve from further damage and slow the progression of vision loss.
